Application 208662
- Type
- ANDA
- Sponsor
- ACP NIMBLE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TAZAROTENE | TAZAROTENE | CREAM;TOPICAL | 0.1% | No | No |
| 002 | TAZAROTENE | TAZAROTENE | CREAM;TOPICAL | 0.05% | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0713-0670 | Tazarotene | Tazarotene | G&W Laboratories, Inc. | ANDA | Current |
| 0713-0670 | Tazarotene | Tazarotene | Cosette Pharmaceuticals, Inc. | ANDA | Current |
| 0713-0670 | Tazarotene | Tazarotene | Cosette Pharmaceuticals, Inc. | ANDA | Current |
| 0713-0670 | Tazarotene | Tazarotene | Cosette Pharmaceuticals, Inc. | ANDA | Current |
| 0713-0764 | Tazarotene | Tazarotene | Cosette Pharmaceuticals, Inc. | ANDA | Current |
| 0713-0764 | Tazarotene | Tazarotene | Cosette Pharmaceuticals, Inc. | ANDA | Current |
| 68308-745 | Tazarotene | TAZAROTENE | Mayne Pharma | ANDA | Current |